Gene therapy: A reality for tomorrow?;La thérapie génique: Une réalité pour demain?

Gastroenterologie Clinique et Biologique

Volumn 29, Issue 6-7, 2005, Pages 724-731

  Cordelier, Pierre ^a   Buscail, Louis ^b  

^a INSERM   (France)

^b CHU RANGUEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; CYTOCHROME P450; CYTOKINE; DNA; GEMCITABINE; HERPESVIRUS VECTOR; IFOSFAMIDE; INTERFERON; INTERLEUKIN 12; INTERLEUKIN 2; LENTIVIRUS VECTOR; ONCOLYTIC VIRUS; ONYX 015; PROTEIN P16INK4A; PROTEIN P53; RECEPTOR SUBTYPE; RETROVIRUS VECTOR; SOMATOSTATIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VIRUS VECTOR;

CANCER CONTROL; CANCER IMMUNOTHERAPY; CANCER REGRESSION; DIGESTIVE SYSTEM CANCER; GENE THERAPY; GENE TRANSFER; HUMAN; LIVER CELL CARCINOMA; NONHUMAN; PANCREAS CANCER; REVIEW; SIMIAN VIRUS 40; SUICIDE GENE; TREATMENT OUTCOME; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS RECOMBINANT;

EID: 21844435748     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0399-8320(05)82162-1     Document Type: Review

References (71)

1. Miller AD. Retrovirus packaging cells. Hum Gene Ther 1990;1:5-14.
2. Roe T, Reynolds TC, Yu G, Brown PO. Integration of murine leukemia virus DNA depends on mitosis. Embo J 1993;12:2099-108.
3. Wang G, Sinn PL, McCray PB, Jr. Development of retroviral vectors for gene transfer to airway epithelia. Curr Opin Mol Ther 2000;2:497-506.
4. Hacein-Bey-Abina S, Le Deist F, Carlier F, Bouneaud C, Hue C, De Villartay JP, et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med 2002;346:1185-93.
5. Hacein-Bey-Abina S, von Kalle C, Schmidt M, Le Deist F, Wulffraat N, McIntyre E, et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 2003;348:255-6.
6. Davis AR, Wivel NA, Palladino JL, Tao L, Wilson JM. Construction of adenoviral vectors. Mol Biotechnol 2001;18:63-70.
7. Yang Y, Haecker SE, Su Q, Wilson JM. Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle. Hum Mol Genet 1996;5:1703-12.
8. Kochanek S. Development of high-capacity adenoviral vectors for gene therapy. Thromb Haemost 1999;82:547-51.
9. Raper SE, Yudkoff M, Chirmule N, Gao GP, Nunes F, Haskal ZJ, et al. A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency. Hum Gene Ther 2002;13:163-75.
10. Strayer DS, Lamothe M, Wei D, Milano J, Kondo R. Generation of recombinant SV40 vectors for gene transfer. Methods Mol Biol 2001;165:103-17.
11. Cordelier P, Van Bockstaele E, Calarota SA, Strayer DS. Inhibiting AIDS in the central nervous system: gene delivery to protect neurons from HIV. Mol Ther 2003;7:801-810.
12. Cordelier P, Zern MA, Strayer DS. HIV-1 proprotein processing as a target for gene therapy. Gene Ther 2003;10:467-77.
13. Cordelier P, Strayer DS. Conditional expression of alpha(1)-antitrypsin delivered by recombinant SV40 vectors protects lymphocytes against HIV. Gene Ther 2003;10:2153-56.
14. Cordelier P, Morse B, Strayer DS. Targeting CCR5 with siRNAs: Using Recombinant SV40-Derived Vectors to Protect Macrophages and Microglia from R5-Tropic HIV. Oligonucleotides 2003;13:281-95.
15. Gao GP, Wilson JM, Wivel NA. Production of recombinant adeno-associated virus. Adv Virus Res 2000;55:529-43.
16. Sanlioglu S, Monick MM, Luleci G, Hunninghake GW, Engelhardt JF. Rate limiting steps of AAV transduction and implications for human gene therapy. Curr Gene Ther 2001;1:137-47.
17. Monahan PE, Jooss K, Sands MS. Safety of adeno-associated virus gene therapy vectors: a current evaluation. Expert Opin Drug Saf 2002;1:79-91.
18. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996;272:263-7.
19. Roy I. Ethical considerations in the use of lentiviral vectors for genetic transfer. Somat Cell Mol Genet 2001;26:175-91.
20. Kichler A, Leborgne C, Coeytaux E, Danos O. Polyethylenimine-mediated gene delivery: a mechanistic study. J Gene Med 2001;3:135-44.
21. Thomas M, Klibanov AM, Lemkine GF, Demeneix BA. Non-viral gene therapy: polycation-mediated DNA delivery Polyethylenimines for in vivo gene delivery. Appl Microbiol Biotechnol 2003;62:27-34.
22. Dolivet G, Merlin JL, Barberi-Heyob M, Ramacci C, Erbacher P, Parache RM, et al. In vivo growth inhibitory effect of iterative wild-type p53 gene transfer in human head and neck carcinoma xenografts using glucosylated polyethylenimine nonviral vector. Cancer Gene Ther 2002;9:708-14.
23. Vernejoul F, Faure P, Benali N, Calise D, Tiraby G, Pradayrol L, et al. Antitumor effect of in vivo somatostatin receptor subtype 2 gene transfer in primary and metastatic pancreatic cancer models. Cancer Res 2002;62:6124-31.
24. Mizuno M, Yoshida J, Sugita K, Inoue I, Seo H, Hayashi Y, et al. Growth inhibition of glioma cells transfected with the human beta-interferon gene by liposomes coupled with a monoclonal antibody. Cancer Res 1990;50:7826-9.
25. Haviv YS, Blackwell J. Transcriptional regulation in cancer gene therapy. Isr Med Assoc J 2001;3:517-22.
26. Prats AC, Prats H. Translational control of gene expression: role of IRESs and consequences for cell transformation and angiogenesis. Prog Nucleic Acid Res Mol Biol 2002;72:367-413.
27. Takehara T, Hayashi N, Yamamoto M, Miyamoto Y, Fusamoto H, Kamada T. In vivo gene transfer and expression in rat stomach by submucosal injection of plasmid DNA. Hum Gene Ther 1996;7:589-93.
28. Schmid RM, Weidenbach H, Draenert GF, Lerch MM, Liptay S, Schorr J, et al. Liposome mediated in vivo gene transfer into different tissues of the gastrointestinal tract. Z Gastroenterol 1994;32:665-70.
29. Lan KH, Kanai F, Shiratori Y, Okabe S, Yoshida Y, Wakimoto H, et al. Tumor-specific gene expression in carcinoembryonic antigen - producing gastric cancer cells using adenovirus vectors. Gastroenterology 1996;111:1241-51.
30. Lozier JN, Yankaskas JR, Ramsey WJ, Chen L, Berschneider H, Morgan RA. Gut epithelial cells as targets for gene therapy of hemophilia. Hum Gene Ther 1997;8:1481-90.
31. Foreman PK, Wainwright MJ, Alicke B, Kovesdi I, Wickham TJ, Smith JG, et al. Adenovirus-mediated transduction of intestinal cells in vivo. Hum Gene Ther 1998;9:1313-21.
32. Brown GR, Thiele DL, Silva M, Beutler B. Adenoviral vectors given intravenously to immunocompromised mice yield stable transduction of the colonic epithelium. Gastroenterology 1997;112:1586-94.
33. Sferra TJ, McNeely D, Johnson PR. Gene transfer to the intestinal tract: a new approach using selective injection of the superior mesenteric artery. Hum Gene Ther 1997;8:681-7.
34. Cheng X, Ming X, Croyle MA. PEGylated adenoviruses for gene delivery to the intestinal epithelium by the oral route. Pharm Res 2003;20:1444-51.
35. During MJ, Xu R, Young D, Kaplitt MG, Sherwin RS, Leone P. Peroral gene therapy of lactose intolerance using an adeno-associated virus vector. Nat Med 1998;4:1131-5.
36. Grossman M, Raper SE, Wilson JM. Transplantation of genetically modified autologous hepatocytes into nonhuman primates: feasibility and short-term toxicity. Hum Gene Ther 1992;3:501-10.
37. Ponder KP, Melniczek JR, Xu L, Weil MA, O'Malley TM, O'Donnell PA, et al. Therapeutic neonatal hepatic gene therapy in mucopolysaccharidosis VII dogs. Proc Natl Acad Sci U S A 2002;99:13102-7.
38. Grimm D, Zhou S, Nakai H, Thomas CE, Storm TA, Fuess S, et al. Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapy. Blood 2003;102:2412-9.
39. Park F, Ohashi K, Kay MA. Therapeutic levels of human factor VIII and IX using HIV-1-based lentiviral vectors in mouse liver. Blood 2000;96:1173-6.
40. Sauter BV, Parashar B, Chowdhury NR, Kadakol A, Ilan Y, Singh H, et al. A replication-deficient rSV40 mediates liver-directed gene transfer and a long-term amelioration of jaundice in gunn rats. Gastroenterology 2000;119:1348-57.
41. Kaneda Y, Nakajima T, Nishikawa T, Yamamoto S, Ikegami H, Suzuki N, et al. Hemagglutinating virus of Japan (HVJ) envelope vector as a versatile gene delivery system. Mol Ther 2002;6:219-26.
42. Hwang RF, Gordon EM, Anderson WF, Parekh D. Gene therapy for primary and metastatic pancreatic cancer with intraperitoneal retroviral vector bearing the wild-type p53 gene. Surgery 1998;124:143-50
43. McClane SJ, Hamilton TE, Burke CV, Raper SE. Functional consequences of adenovirus-mediated murine pancreatic gene transfer. Hum Gene Ther 1997;8:739-46.
44. Salmon P, Oberholzer J, Occhiodoro T, Morel P, Lou J, Trono D. Reversible immortalization of human primary cells by lentivector-mediated transfer of specific genes. Mol Ther 2000;2:404-14.
45. Curran MA, Ochoa MS, Molano RD, Pileggi A, Inverardi L, Kenyon NS, et al. Efficient transduction of pancreatic islets by feline immunodeficiency virus vectors 1. Transplantation 2002;74:299-306.
46. Hamilton A, Piccart M. The contribution of molecular markers to the prediction of response in the treatment of breast cancer: a review of the literature on HER-2, p53 and BCL-2. Ann Oncol 2000;11:647-63.
47. Warren RS, Kim DH. Liver-directed viral therapy for cancer p53-targeted adenoviruses and beyond. Surg Oncol Clin N Am 2002;11:571-88
48. Ghaneh P, Greenhalf W, Humphreys M, Wilson D, Zumstein L, Lemoine NR, et al. Adenovirus-mediated transfer of p53 and p16(INK4a) results in pancreatic cancer regression in vitro and in vivo. Gene Ther 2001;8:199-208.
49. Tatebe S, Matsuura T, Endo K, Teramachi K, Nakamura T, Sato K, et al. Adenovirus-mediated transfer of wild-type p53 gene results in apoptosis or growth arrest in human cultured gastric carcinoma cells. Int J Oncol 1999;15:229-35.
50. Hemmati PG, Gillissen B, von Haefen C, Wendt J, Starck L, Guner D, et al. Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis. Oncogene 2002;21:3149-61.
51. Moolten FL. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res 1986;46:5276-81.
52. Moolten FL, Wells JM. Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J Natl Cancer Inst 1990;82:297-300.
53. Kanai F, Lan KH, Shiratori Y, Tanaka T, Ohashi M, Okudaira T, et al. In vivo gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene. Cancer Res 1997;57:461-5.
54. Evoy D, Hirschowitz EA, Naama HA, Li XK, Crystal RG, Daly JM, et al. In vivo adenoviral-mediated gene transfer in the treatment of pancreatic cancer. J Surg Res 1997;69:226-31.
55. Sung MW, Yeh HC, Thung SN, Schwartz ME, Mandeli JP, Chen SH, et al. Intratumoral adenovirus-mediated suicide gene transfer for hepatic metastases from colorectal adenocarcinoma: results of a phase I clinical trial. Mol Ther 2001;4:182-91.
56. Shand N, Weber F, Mariani L, Bernstein M, Gianella-Borradori A, Long Z, et al. A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group. Hum Gene Ther 1999;10:2325-35.
57. Peron JM, Couderc B, Rochaix P, Douin-Echinard V, Asnacios A, Souque A, et al. Treatment of murine hepatocellular carcinoma using genetically modified cells to express interleukin-12. J Gastroenterol Hepatol 2004;19:388-96.
58. Motoi F, Sunamura M, Ding L, Duda DG, Yoshida Y, Zhang W, et al. Effective gene therapy for pancreatic cancer by cytokines mediated by restricted replication-competent adenovirus. Hum Gene Ther 2000;11:223-35.
59. Meng WS, Butterfield LH, Ribas A, Dissette VB, Heller JB, Miranda GA, et al. alpha-Fetoprotein-specific tumor immunity induced by plasmid prime-adenovirus boost genetic vaccination. Cancer Res 2001;61:8782-86.
60. Arnold R, Simon B, Wied M. Treatment of neuroendocrine GEP tumours with somatostatin analogues: a review. Digestion 2000;62:84-91.
61. Buscail L, Saint-Laurent N, Chastre E, Vaillant JC, Gespach C, Capella G, et al. Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer. Cancer Res 1996;56:1823-7.
62. Cordelier P, Esteve JP, Bousquet C, Delesque N, O'Carroll AM, Schally AV, et al. Characterization of the antiproliferative signal mediated by the somatostatin receptor subtype sst5. Proc Natl Acad Sci U S A 1997;94:9343-8.
63. Benali N, Cordelier P, Calise D, Pages P, Rochaix P, Nagy A, et al. Inhibition of growth and metastatic progression of pancreatic carcinoma in hamster after somatostatin receptor subtype 2 (sst2) gene expression and administration of cytotoxic somatostatin analog AN-238. Proc Natl Acad Sci U S A 2000;97:9180-5.
64. Rochaix P, Delesque N, Esteve JP, Saint-Laurent N, Voight JJ, Vaysse N, et al. Gene therapy for pancreatic carcinoma: local and distant antitumor effects after somatostatin receptor sst2 gene transfer. Hum Gene Ther 1999;10:995-1008.
65. Guillemet J, Saint-Laurent N, Rochaix P, Cuvillier O, Levade T, Schally AV, et al. Somatostatin receptor subtype 2 sensitizes human pancreatic cancer cells to death ligand-induced apoptosis. Proc Natl Acad Sci U S A 2003;100:155-60.
66. Gilly FN, Beaujard A, Bienvenu J, Trillet Lenoir V, Glehen O, Thouvenot D, et al Gene therapy with Adv-IL-2 in unresectable digestive cancer: phase I-II study, intermediate report. Hepatogastroenterology 1999;46:1268-73.
67. Mulvihill S, Warren R, Venook A, Adler A, Randlev B, Heise C, et al. Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial. Gene Ther 2001;8:308-15.
68. Lohr M, Hoffmeyer A, Kroger J, Freund M, Hain J, Holle A, et al. Microencapsulated cell-mediated treatment of inoperable pancreatic carcinoma. Lancet 2001;357:1591-2.
69. Hecht JR, Bedford R, Abbruzzese JL, Lahoti S, Reid TR, Soetikno RM, et al. A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma. Clin Cancer Res 2003;9:555-61.
70. Sangro B, Mazzolini G, Ruiz J, Herraiz M, Quiroga J, Herrero I, et al. Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors. J Clin Oncol 2004;22:1389-97.
71. Chang KJ, Senzer N, Chung T, J. Hecht R, Vogel S, Rosemurgy A, et al. A novel gene transfer therapy against pancreatic cancer (tnferade) delivered by endoscopic ultrasound and percutaneous guided fine needle injection. Gastroenterology 2004:126 Supp, A188.